BRIEF published on 09/03/2024 at 22:20, 2 years 1 month ago Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference Biotechnology Webcast Fireside Chat NANOBIOTIX Investment Conference
PRESS RELEASE published on 09/03/2024 at 22:15, 2 years 1 month ago Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference Nanobiotix to present at H.C. Wainwright 26th Annual Global Investment Conference. Company management to participate in fireside chat on September 11, 2024 Biotechnology Cancer H.C. Wainwright NANOBIOTIX Global Investment Conference
BRIEF published on 08/08/2024 at 22:20, 2 years 2 months ago Nanobiotix: Information on Voting Rights and Shares as of July 31, 2024 Share Capital Voting Rights Actions Sotck Exchange NANOBIOTIX
PRESS RELEASE published on 08/08/2024 at 22:15, 2 years 2 months ago Voting Rights and Shares Capital of the Company Nanobiotix announces monthly publication of voting rights and shares capital in compliance with French Commercial Code. Learn more about the company's disruptive biotechnology approaches Voting Rights French Commercial Code Biotechnology Shares Capital NANOBIOTIX
BRIEF published on 07/09/2024 at 22:20, 2 years 3 months ago Voting Rights and Shares Capital of Nanobiotix Voting Rights Shares Euronext Nasdaq NANOBIOTIX
PRESS RELEASE published on 07/09/2024 at 22:15, 2 years 3 months ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital information as per French Commercial Code. Check the latest figures for June 30, 2024 Euronext Paris Voting Rights French Commercial Code Shares Capital NANOBIOTIX
BRIEF published on 07/03/2024 at 15:54, 2 years 3 months ago Threshold crossings at NANOBIOTIX by Goldman Sachs Group AMF Goldman Sachs NANOBIOTIX Threshold Crossings
BRIEF published on 06/12/2024 at 22:20, 2 years 4 months ago Nanobiotix hosts virtual discussion on the potential of NBTXR3 in cancer treatments Immunotherapy Head And Neck Cancer NANOBIOTIX NBTXR3 Virtual Discussion
PRESS RELEASE published on 06/12/2024 at 22:15, 2 years 4 months ago NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024 Nanobiotix to host virtual KOL event discussing NBTXR3 combined with immunotherapy in head and neck cancer and beyond on June 18, 2024 Immunotherapy Head And Neck Cancer NANOBIOTIX NBTXR3 Virtual KOL Event
BRIEF published on 06/11/2024 at 22:20, 2 years 4 months ago Nanobiotix: Monthly Information on Voting Rights and Shares Voting Rights Euronext Actions Nasdaq NANOBIOTIX
Published on 10/30/2026 at 23:35, 1 day 10 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 11 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 1 day 15 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 19 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/01/2026 at 05:00, 5 hours 29 minutes ago 2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 17 hours 54 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 11 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 1 day 11 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 12:00, 1 day 22 hours ago Capital increase through exercise of subscription rights
